Navigation Links
$10 Million Verdict Against Johnson & Johnson Unit for Toxic Motrin Reaction, Announces The Jensen Law Firm
Date:5/24/2011

PHILADELPHIA, May 24, 2011 /PRNewswire/ -- Members of Fort Worth, Texas-based Jensen Law Firm (www.stevensjohnsonsyndrome.org) are pleased to announce a $10 million verdict in compensatory damages against Johnson & Johnson's McNeil Consumer Products (NYSE: JNJ) unit on behalf of 13-year-old Brianna Maya and her family. Brianna suffered disfiguring, life-altering skin burns and permanent blindness after she was given Children's Motrin to treat a fever and cough in 2000. (Alicia E. Maya, et al. v. Johnson & Johnson, et al., Case No. 002879, Court of Common Pleas, Philadelphia County, Pennsylvania)

When Brianna was 3 years old, she was given Children's Motrin. Soon after, she developed a rash, skin lesions, eye infections, and lung damage. Her family didn't know at the time that Children's Motrin had been linked to Toxic Epidermal Necrolysis (TEN) and Stevens-Johnson Syndrome (SJS), severe allergic reactions that can cause patients' skin to burn off, leave patients blind and disfigured.  Now 13, Brianna continues to experience the effects of taking the drug, including:

  • blindness in one eye, corneal scarring in both eyes, and recurring eye infections
  • ongoing eye surgeries needed to maintain vision
  • permanent disfigurement to her face, eyelids, and body after 84 percent of her skin was burned when she initially took the medicine
  • permanent lung damage, including a 50 percent loss of lung capacity with recurring lung infections and pneumonia
  • brain damage and recurring seizures
  • internal and external scarring resulting in permanent loss of reproductive system

Jurors deliberated for approximately 10 hours before holding J&J's McNeil Consumer Products unit liable for Brianna's injuries and awarded her $10 million.   Her recoverable medical expenses were less than $2.5 million. The jury found that McNeil Consumer Products was negligent in failing to adequately warn about the risks of over-the-counter Children's Motrin and that this negligence was a cause of Brianna's injuries.

“Justice has been served,” said attorney Keith Jensen, founding partner of The Jensen Law Firm. “Drug companies must understand that if they fail to warn consumers about the known risks of their products, juries will hold them accountable.  How many parents would buy Children’s Motrin if they were told, as J&J and McNeil admitted at trial, that Children’s Tylenol was safer and more effective than Children’s Motrin and does not cause SJS, TEN or resultant blindness, disfigurement or lung damage?”

Members of The Jensen Law Firm have handled similar cases in the past. In September 2010, Jensen obtained a $21 million verdict against Mutual Pharmaceutical on behalf of a client who suffered from TEN stemming from taking a different NSAID (not Ibuprofen/Motrin but sulindac). This remains the largest jury verdict in New Hampshire history. (Karen L. Bartlett v. Mutual Pharmaceutical Company, Inc., Civil No. 08-358-JL, U.S. District Court, District of New Hampshire)

Johnson & Johnson is the world's second-largest seller of medical products and recalled more than 40 consumer brands last year—including children's versions of Tylenol, Motrin and St. Joseph Aspirin.

About The Jensen Law Firm

The Jensen Law Firm represents individuals and families in cases involving catastrophic personal injuries, death, or financial ruin resulting from the negligence or wrongdoing of drug manufacturers and others. To learn more, visit www.stevensjohnsonsyndrome.org.

For more information, contact:
Abbey Smith
Phone: 615-296-1078
Email: abbey@cjadvertising.com


'/>"/>
SOURCE The Jensen Law Firm
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd.
2. University Hospitals Seidman Cancer Center Announces $30 Million Proton Therapy Center
3. TechPrecision Corporation Receives $1.6 Million in New Orders from Existing Customers
4. Isis Earns $3 Million Payment as Collaboration With GSK Expands
5. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
6. PDL BioPharma, Inc. Prices Offering of $135.0 Million of Convertible Senior Notes Due 2015
7. Vermillion Reports Financial Results for the First Quarter 2011
8. The Female Health Companys Brazilian Distributor, Semina, Awarded Contract For Up To 20 Million FC2 Female Condoms
9. HeartWare International Reports First Quarter 2011 Revenues of $18.0 Million; 68% Increase From $10.7 Million in First Quarter 2010
10. Spring Bank Pharmaceuticals Awarded $3.9 Million RO1 NIH Grant to Advance Innovative Hepatitis Program
11. Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trusts Grow What Works Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... CARLSBAD, Calif. , July 10, 2017  The ... in Boston, MA at the ... unequaled value and unparalleled access to global decision makers ... to draw 800+ life science leaders during two impactful ... Boston, and provides delegates with additional networking opportunities with ...
(Date:7/5/2017)... England , July 5, 2017 Wolfmet ... perfect answer as physics and manufacturing combine to progress molecular ... thyroid, existing SPECT systems are unable to accurately quantify the ... only limited information regarding the success of this radiotherapy treatment ... ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
Breaking Medicine Technology:
(Date:7/21/2017)... Norwalk, Connecticut (PRWEB) , ... July 21, 2017 , ... ... data from HealthCareMandA.com . The number of hospital acquisitions rose to 23 in ... quarter of 2017, and up 15% from the 20 announced deals in the year-ago ...
(Date:7/21/2017)... ... July 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... violence and aggression to solve problems and pleads with world leaders to be more open ... do not bring peace. He says there is a peaceful and positive way to solve ...
(Date:7/21/2017)... ST. LOUIS, MO (PRWEB) , ... July 21, 2017 , ... ... are born knowing how to tie their shoes,” says Suzanne Tucker, Founder of St. ... created the Time-In Toolkit, which launches on Kickstarter on Monday, July 21st. , ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) ... of life a decade after surgery, though activity levels decline over time. The ...
(Date:7/20/2017)... ... ... TransPixel Volume 2 is a set of transitions that create a pixel ... horizontal and vertical lines of pixels and sorts their pixels by darkness, brightness, or ... can be changed using a drop-down menu. Create amazing and artistic transitions using TransPixel ...
Breaking Medicine News(10 mins):